ArticleAntimicrobial agents and chemotherapy2025

Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?

Manjunath P Pai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.